Sheila Savageau Joins the IntoValue Board of Directors

August 19, 2024 9:00 AM

A national leader in direct to employer healthcare arrangements joins IntoValue BoardWASHINGTON, DC / ACCESSWIRE / August 19, 2024 / IntoValue, Inc, a trailblazing healthcare direct-to-employer enablement company, proudly announces the appointment of Sheila Savageau to its Board of Directors. Sheila Savageau A national leader in direct to employer healthcare innovation, Sheila Savage Sheila Savageau brings a wealth of experience to IntoValue,...

Read more

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

August 19, 2024 8:00 AM

FORT LAUDERDALE, FL / ACCESSWIRE / August 19, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 second quarter report with the Securities and Exchange Commission. The Company reported gross revenues of $9,303,067 for the three months ended June 30,...

Read more

MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End

August 19, 2024 7:30 AM

MIAMI, FL / ACCESSWIRE / August 19, 2024 / MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) "MIRA" or the "Company"), a leading pre-clinical-stage pharmaceutical company, is pleased to provide a comprehensive update on its recent achievements and scientific advancements as it nears a crucial milestone: the submission of its Investigational New Drug (IND) application by the end of the year. This update highlights the company's strategic progress,...

Read more

MindBio Announces Sustained Antidepressant Response 3-Months Post Treatment in Microdosing Depression Clinical Trials

August 19, 2024 7:20 AM

MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a leading biopharmaceutical company in psychiatric medicine development, is delighted to report durability data from Phase 2A clinical trials in depressed patients testing MB22001, MindBio's proprietary self-administered take home microdose of Lysergic Acid Diethylamide (LSD). We are pleased to report a significant and sustained antidepressant response in patient...

Read more

Simulab Corporation Releases New AirwayBaby(TM) Infant Airway Management Trainer

August 19, 2024 7:00 AM

Healthcare Simulation: Infant Airway Management Trainer SEATTLE, WA / ACCESSWIRE / August 19, 2024 / Simulab Corporation, a leader in medical simulation technology, is excited to announce the launch of its latest human patient simulator, the AirwayBaby™ Infant Airway Management Trainer. This advanced training tool simulates airway management of zero to six-month-old infants for healthcare professionals worldwide.Simulab's New AirwayBaby™...

Read more

NanoViricides Continues Its March Towards a Phase II Clinical Trial of NV-387 -
A Potentially Revolutionary First Line Antiviral Therapy for RSV, COVID, and Other Viral Infections

August 19, 2024 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, is providing an update on its clinical program activities.Dr. Anil Diwan, the Company's President, and Executive Chairman, is currently visiting with various expert professionals with the objective of developing a Phase II clinical trial plan and corresponding clinical protocol for a Phase II clinical trial of the...

Read more

Asentech Named PM360 Trailblazer Award Finalist for App/Digital Solution Category

August 18, 2024 5:30 PM

PM360, a monthly magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries, has named Asentech LLC as an APP/DIGITAL SOLUTION finalist.The Trailblazer Awards were established in 2009 to recognize and honor achievements in healthcare marketing. All of the award finalists and winners are judged and selected by the PM360 Editorial Advisory Board, comprising some of the most forward-thinking leaders in...

Read more

Life Rx Celebrates Helping 35,000 Patients Achieve Wellness Success

August 17, 2024 10:55 AM

LifeRx, a leading provider of personalized health solutions, is proud to announce that it has successfully supported 35,000 patients across the United States in their journey to improved wellness. This remarkable milestone reflects the company's commitment to offering safe, effective, and accessible treatment options for those seeking to enhance their overall health. LifeRx's wellness program, powered by GLP-1 and various treatments, a...

Read more

Dr. Gianluca Cerri, MD Launches Campaign to Enhance Rural Medicine in Louisiana

August 17, 2024 8:00 AM

Dr. Gianluca Cerri, MD, a renowned emergency medicine physician based in Baton Rouge, is launching a comprehensive campaign to bolster rural healthcare across Louisiana. The initiative, aimed at addressing the unique challenges faced by rural communities, seeks to improve access to medical services, enhance healthcare infrastructure, and recruit healthcare professionals to underserved areas.Addressing the Need for Rural HealthcareRural...

Read more

Inside the Mind of a Healthcare Innovator: Shamus McGuire’s Success Secrets

August 17, 2024 6:30 AM

Shamus McGuire, a distinguished healthcare executive, is sharing his insights on successful leadership strategies within the healthcare industry. With over 28 years of experience, McGuire has played a pivotal role in enhancing operational efficiency and service delivery across top healthcare organizations. His career is marked by strategic innovation and a commitment to excellence, making him a respected figure in the healthcare sector.Raised in...

Read more

It Turns Out That at MindTrek, Couples on the Brink Are Seeing Results With Psilocybin Therapy

August 16, 2024 6:00 PM

When Scott Holden asked Alexis Mollomo to help him start up MindTrek, A Psilocybin service center, they received many queries from people at an impasse in their relationship or one person in a caregiver role and the other in need of help.It became clear to them that the person concerned for the other, and often the one reaching out to the office, was also the individual who could benefit from this transformative medicine. Within time they...

Read more

Dr. Amir Bajoghli and Skin & Laser Dermatology Center Introduce Sculptra Aesthetic for Advanced Facial Rejuvenation

August 16, 2024 3:00 PM

Dr. Amir Bajoghli and the Skin & Laser Dermatology Center are excited to announce the addition of Sculptra Aesthetic to their comprehensive range of facial rejuvenation services.MCLEAN, VA / ACCESSWIRE / August 16, 2024 / Dr. Amir Bajoghli and the Skin & Laser Dermatology Center are excited to announce the addition of Sculptra Aesthetic to their comprehensive range of facial rejuvenation services. This advanced injectable treatment offers a...

Read more

How CARE Triangulated Global Climate Data, Research With Partners, and Program Data To Work Towards Climate Justice

August 16, 2024 12:30 PM

New research with partners shows that integrating gender transformative approaches, climate adaptation, and resilience building helps achieve livelihoods growth. How well is CARE doing this in areas vulnerable to climate change?NORTHAMPTON, MA / ACCESSWIRE / August 16, 2024 / CARE Figure 1: CARE is making an impact in most highly climate vulnerable countries but there are opportunities to better integrate...

Read more

Dr. Paul Vitenas Named on Texas Super Doctors(R) for 2024 in Texas Monthly's 21st Year Celebration

August 16, 2024 9:00 AM

Celebrated for His Expertise in Breast Augmentation, Facial Rejuvenation and Body Contouring, Dr. Vitenas Continues to Lead in Patient Care, Earning Recognition on the Texas Super Doctors® List for 2024HOUSTON, TX / ACCESSWIRE / August 16, 2024 / Dr. Paul Vitenas, a board-certified plastic surgeon in Houston, Texas, has been named to the 2024 Texas Super Doctors® list. Featured in Texas Monthly magazine, this recognition underscores Dr. Vitenas'...

Read more

Results From European Randomized Controlled Study Using XVIVO's Heart Technology Published in The Lancet

August 16, 2024 8:45 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / August 16, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today, the results of the European randomized controlled clinical trial investigating the use of XVIVO's heart technology were published in the prestigious scientific journal The Lancet[1]. The trial compared outcomes for patients who received a donor heart preserved either on ice, the current standard method, or using XVIVO's Heart Assist...

Read more

Safe Seated Mammography Using Enable Me's VELA Mammography Chair Can Improve Image Clarity this World Breast Cancer Research Day Aug. 18

August 16, 2024 8:30 AM

The technologically-advanced, clinically designed VELA Mammography Chair is an FDA-approved tool from Enable Me, a VELA Medical company, that is revolutionizing how women experience their mammograms by providing a safe, comfortable seated option that results in clearer imaging and can reduce the risk of falls. "World Breast Cancer Research Day this Sunday is a good time to consider that cancer detection is greatly improved when the patient is...

Read more

Revolutionizing Nail Art: BTArtboxnails Launches XCOATTIPS(R) Cat Eye Series

August 15, 2024 6:15 PM

BTArtboxnails is thrilled to announce the official launch of its highly anticipated XCOATTIPS® Cat Eye Series. For years, cat-eye nails have been a timeless trend, adored by nail enthusiasts around the globe. Yet, achieving that perfect cat-eye effect has remained a challenge-until now. BTArtboxnails, a leader in innovative nail solutions since 2013, has crafted an easy and convenient way for everyone to achieve salon-quality cat-eye nails at...

Read more

Encision Reports First Quarter Fiscal Year 2025 Results

August 15, 2024 6:15 PM

Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 first quarter that ended June 30, 2024.The Company posted quarterly product net revenue of $1.59 million and service net revenue of $39 thousand, or total net revenue of $1.63 million for a quarterly...

Read more

CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event

August 15, 2024 3:00 PM

CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day.Qualified investors can...

Read more

Consensus Health Wins Stevie(R) Award In 2024 International Business Awards(R)

August 15, 2024 1:45 PM

MARLTON, NJ / ACCESSWIRE / August 15, 2024 / Consensus Health, a leading New Jersey-based healthcare organization with a physician-led medical group and an Independent Physician Alliance (IPA), announced today it was named winner in The 21st Annual International Business Awards® (IBAs). The Company earned a bronze Stevie® Award in the Company of the Year - Health Products & Services - Large category.The International Business Awards are the...

Read more